Profile
Michael Reusch is Chief Medical Officer at Guard Therapeutics International AB since 2022.
Formerly, Dr. Reusch was Senior Director-Medical at Astellas Pharma Global Development, Inc. Dr. Reusch earned a doctorate from the University of Duisburg-Essen.
Michael Reusch active positions
| Companies | Position | Start |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Chief Tech/Sci/R&D Officer | 2021-12-31 |
Former positions of Michael Reusch
| Companies | Position | End |
|---|---|---|
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Training of Michael Reusch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of Duisburg-Essen
University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Guard Therapeutics International AB
Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
- Stock Market
- Insiders
- Michael Reusch
















